OLIPUDASE ALFA
Drug
GENZYME CORPORATION
Total Payments
$10,909
Transactions
14
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $10,909 | 14 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,726 | 2 | 89.2% |
| Travel and Lodging | $855.10 | 4 | 7.8% |
| Food and Beverage | $327.78 | 8 | 3.0% |
Ad
Manufacturing Companies
- GENZYME CORPORATION $10,909
Product Information
- Type Drug
- Total Payments $10,909
- Total Doctors 2
- Transactions 14
About OLIPUDASE ALFA
OLIPUDASE ALFA is a drug associated with $10,909 in payments to 2 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.
Payment data is available from 2019 to 2019. In 2019, $10,909 was paid across 14 transactions to 2 doctors.
The most common payment nature for OLIPUDASE ALFA is "Consulting Fee" ($9,726, 89.2% of total).